Range Low Price High Price Comment
30 days $1.24 $2.05 Wednesday, 27th Mar 2024 ADAP stock ended at $1.58. This is 3.95% more than the trading day before Tuesday, 26th Mar 2024. During the day the stock fluctuated 10.54% from a day low at $1.47 to a day high of $1.63.
90 days $0.620 $2.05
52 weeks $0.420 $2.05

Historical Adaptimmune Therapeutics plc prices

Date Open High Low Close Volume
2023-11-01 $0.550 $0.565 $0.528 $0.540 382 807
2023-10-31 $0.570 $0.570 $0.530 $0.541 282 523
2023-10-30 $0.580 $0.590 $0.540 $0.555 197 565
2023-10-27 $0.569 $0.580 $0.550 $0.550 227 989
2023-10-26 $0.596 $0.599 $0.555 $0.560 559 638
2023-10-25 $0.620 $0.620 $0.570 $0.595 322 348
2023-10-24 $0.642 $0.650 $0.600 $0.613 297 212
2023-10-23 $0.600 $0.620 $0.555 $0.600 618 111
2023-10-20 $0.580 $0.600 $0.550 $0.565 340 811
2023-10-19 $0.565 $0.587 $0.565 $0.580 140 027
2023-10-18 $0.621 $0.629 $0.565 $0.587 810 423
2023-10-17 $0.646 $0.662 $0.610 $0.629 604 982
2023-10-16 $0.660 $0.667 $0.621 $0.665 657 319
2023-10-13 $0.669 $0.669 $0.640 $0.656 537 755
2023-10-12 $0.689 $0.699 $0.650 $0.669 477 095
2023-10-11 $0.671 $0.700 $0.671 $0.680 206 210
2023-10-10 $0.671 $0.719 $0.671 $0.680 330 819
2023-10-09 $0.701 $0.710 $0.675 $0.686 245 122
2023-10-06 $0.700 $0.735 $0.700 $0.713 165 376
2023-10-05 $0.704 $0.729 $0.700 $0.720 268 433
2023-10-04 $0.754 $0.770 $0.669 $0.728 878 502
2023-10-03 $0.711 $0.800 $0.695 $0.760 594 246
2023-10-02 $0.780 $0.800 $0.710 $0.750 451 830
2023-09-29 $0.770 $0.81 $0.750 $0.780 207 861
2023-09-28 $0.80 $0.81 $0.765 $0.786 184 994
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT